Nutraceutical client startup The Good Bug has raised Rs 100 crore in new funding from Susquehanna Asia VC together with participation from present investor Hearth Ventures.
“This new capital infusion might be pivotal in accelerating our analysis and growth efforts, driving floor breaking improvements in intestine well being by rigorous R&D,” stated Keshav Biyani, Co-founder of The Good Bug in a press word.
“Moreover, we’ll bolster our advertising and marketing and distribution methods to boost client consciousness and increase our attain throughout India. Attracting top-tier expertise throughout analysis, know-how, science, and enterprise will additional strengthen our basis,” added Biyani.
.thumbnailWrapper{
width:6.62rem !vital;
}
.alsoReadTitleImage{
min-width: 81px !vital;
min-height: 81px !vital;
}
.alsoReadMainTitleText{
font-size: 14px !vital;
line-height: 20px !vital;
}
.alsoReadHeadText{
font-size: 24px !vital;
line-height: 20px !vital;
}
}
The Good Bug gives intestine well being options together with s clinically examined synbiotic formulation, probiotics, prebiotic fibers, kombuchas, water kefirs, and fermented pickles and so on.
Based in 2022 by Keshav Biyani and Prabhu Karthikeyan, the corporate final raised $4 million in 2024 in its prolonged sequence A spherical led by Sharrp Ventures, the household workplace of Marico Group Chairman Harsh Mariwala. Hearth joined the corporate’s captable in 2023 in a sequence A spherical.
“What units TGB aside is the power of its management workforce and their distinctive capacity to execute on their imaginative and prescient. With sturdy momentum and a transparent technique, the corporate is wellpositioned to capitalize on the macro tailwinds of India’s quickly increasing nutraceuticals market,” shared Bhavani Rana, Funding Advisor to Susquehanna Asia VC because the rationale behind funding.
Edited by Jyoti Narayan
